May. 28 at 1:55 PM
$INBS Can they 'get it right' this time. Warned someone that
their prior trials were not 'robust' enough, they seemed to be trying
to get away with minimum costs for the trials vs doing more than
enough. Been proven right on that aspect. Bought my 1st shares at sub
$4 (with cheaper adds made) since it dropped off the
$20 mark post the r/split and just made my last add this morn (pre PH 3 data dumps) as its chart is looking even nicer (if you are a buyer/expect it to pass this time).
Agree with
$20/sh given its small share count/market cap at present.
But do expect them to sell some more shares IF the ph 3s pass to fund
the efforts to get a med device application updated/submitted.
Good luck..
